KANSAS CITY, Kan., Oct. 21, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals will host an investor day in New York on November 12, 2015. The event will focus on the Company's R&D pipeline, commercialization of products and financial outlook.
|
Aratana Therapeutics 2015 Investor Day | ||
|
November 12, 2015 | ||
|
9:00 – 11:30 a.m. ET (registration starts at 8:30 a.m. ET) | ||
|
New York City |
Interested parties will be required to register for this event and will receive additional details in the coming weeks.
About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The Company's pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.
Contacts
For investor inquires:
Aratana Therapeutics, Inc.
Craig Tooman
ctooman@aratana.com; (913) 353-1026
For media inquiries:
Tiberend Strategic Advisors, Inc.
Andrew Mielach
amielach@tiberend.com; (212) 375-2694
SOURCE Aratana Therapeutics, Inc.